Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROTECT-U
2017-000514-35Phase 3Active
- Sponsor
- Medical Faculty Mannheim of Heidelberg University
- Start
- Apr 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of aspirin in brain aneurysm (IA) and Saccular cerebral aneurysm (2 arms), sponsored by Medical Faculty Mannheim of Heidelberg University. Started Apr 2018; status: active.
02
Drugs
aspirin
03
Conditions
brain aneurysm (IA)Saccular cerebral aneurysm
Beyond the preview
Go deeper on 2017-000514-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000514-35.